ondansetron has been researched along with Hallucinations in 3 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zoldan, J | 2 |
| Friedberg, G | 2 |
| Goldberg-Stern, H | 1 |
| Melamed, E | 2 |
| Weizman, A | 1 |
| Nevins, M | 1 |
2 trials available for ondansetron and Hallucinations
| Article | Year |
|---|---|
Ondansetron for hallucinosis in advanced Parkinson's disease.
Topics: Aged; Female; Hallucinations; Humans; Male; Middle Aged; Ondansetron; Parkinson Disease | 1993 |
Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Delusions; Female; Hallucinations; Humans; Levodopa; | 1996 |
1 other study available for ondansetron and Hallucinations
| Article | Year |
|---|---|
Charles Bonnet syndrome.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Female; Hallucinations; Humans; Ondansetron; Syndrome | 1997 |